Gynecologic Cancer
Feature
As government-funded cancer research sags, scientists fear U.S. is ‘losing its edge’
Less and less of the research presented at a prominent cancer conference is supported by the National Institutes of Health, a development that...
Expert Commentary
Does laparoscopic versus open abdominal surgery for stage I endometrial cancer affect oncologic outcomes?
No. There were no significant differences in disease-free survival, recurrence and location of recurrence, or overall survival in...
From the Journals
Pembrolizumab shows some activity against advanced endometrial cancer
(Keytruda)
From the Journals
Deep infiltrating endometriosis lesions harbor cancer-driver mutations
A finding of cancer-related mutations in noncancerous lesions is “surprising” and raises new questions about the pathobiology of endometriosis.
Conference Coverage
Endometrial cancer rates increased following WHI
SAN DIEGO – Endometrial cancer rates spiked between 2006 and 2014, according to a large analysis of national data.
Clinical Review
2017 Update on cervical disease
Findings from 2 studies answer key questions regarding cervical cancer screening. Plus, an explosion of new molecular technology applications has...
From the Journals
Cervical cancer incidence declines after age 85
Women should stop attending their cervical screening appointments at the recommended age of 65 and over only if they have an adequate prior...
Gynecologic Oncology Consult
Optimizing surveillance for gynecologic cancers
High-quality surveillance care requires vigilance in the detection of recurrence, but also in the avoidance of unnecessary, costly, and inaccurate...
From the Journals
Racial disparities in ovarian cancer care persist until death
Care for black and Hispanic women with ovarian cancer misses the mark on many quality care measures at the end of life.
Conference Coverage
Neoadjuvant chemotherapy induces mutational, molecular shifts in ovarian cancers
NATIONAL HARBOR, MD. – Neoadjuvant chemotherapy was associated with changes in gene expression and associated pathways in high-grade serous...
Gynecologic Oncology Consult
Risk for obstetric complications when treating cervical dysplasia
Consider recommending a 12-month interval between treatment and pregnancy to ensure resolution of high-grade dysplasia.